Goldman Sachs Group Inc Relay Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,935,167 shares of RLAY stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,935,167
Previous 2,077,995
6.87%
Holding current value
$12.6 Million
Previous $5.44 Million
22.98%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding RLAY
# of Institutions
213Shares Held
173MCall Options Held
0Put Options Held
36.1K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$182 Million0.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct13.4MShares$87.5 Million0.1% of portfolio
-
Commodore Capital LP New York, NY13.4MShares$86.9 Million4.31% of portfolio
-
Casdin Capital, LLC New York, NY11.4MShares$74.2 Million5.53% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$68.6 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $783M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...